Latest releases

27.12.2017

FN, LR

Herantis Pharma expands on timeline for Lymfactin studies
04.12.2017

FN

Herantis Pharma Plc’s financial reporting schedule and annual general meeting in 2018
10.11.2017

FN

Herantis Pharma’s Manager’s Transactions
10.11.2017

FN

Herantis Pharma’s Manager’s Transactions
10.11.2017

FN

Herantis Pharma’s Manager’s Transactions
10.11.2017

FN

Herantis Pharma’s Manager’s Transactions
09.11.2017

FN

Herantis Pharma Plc’s directed share issue
09.11.2017

FN

Decisions of Herantis Pharma Plc’s Extraordinary General Meeting of Shareholders
19.10.2017

FN

Notice to convene Herantis Pharma Plc’s Extraordinary General Meeting of Shareholders
19.10.2017

FN, LR

Herantis Pharma Plc is planning a directed share issue to a limited number of investors and the company’s directors regarding the financing of the Lymfactin Phase 2 clinical study

Quick links

Analyst Coverage »

Financial Calendar »

General Meetings »

Financial Information »

Share Information »

Share Monitor »

Investor Relations »

Corporate Governance »